Pemirolast

CHEMBL1201198 Phase 4 已批准 Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
228.2 g/mol
LogP
-0.3
Phase
4

A mast cell stabilizer and inhibitor of certain mediator release, used as eye drops to treat allergic conjunctivitis and in some countries for allergic rhinitis and asthma prevention. It prevents the degranulation of mast cells and reduces release of histamine and other inflammatory substances.

分子量

228.2100 g/mol

LogP

-0.30

TPSA

87.10 Ų

Lipinski 五规则

符合

治疗领域

Pharmacokinetics (PK)

Pharmacodynamics (PD)

二维结构

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cc1cccn2c(=O)c(-c3nnn[nH]3)cnc12

InChI

InChI=1S/C10H8N6O/c1-6-3-2-4-16-9(6)11-5-7(10(16)17)8-12-14-15-13-8/h2-5H,1H3,(H,12,13,14,15)

Molecular Formula

C10H8N6O

HBD / HBA

1 / 5

可旋转键数

1

重原子数

17

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

常见问题

A mast cell stabilizer and inhibitor of certain mediator release, used as eye drops to treat allergic conjunctivitis and in some countries for allergic rhinitis and asthma prevention. It prevents the degranulation of mast cells and reduces release of histamine and other inflammatory substances.

Yes, Pemirolast is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201198. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 57697. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

医疗免责声明

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.